| Carnitine fraction (µmol/L) |
Controls |
Patients |
P value |
| F ree carnitine (C0) |
33.54±6.42 |
15.84±9.70* |
<0.01 |
| Acetylcarnitine (C2) |
6.65 ± 4.4 |
3.97 ± 2.59* |
<0.01 |
| Propionylcarnitine (C3) |
0.487 ± 0.16 |
0.404 ± 0.33 |
0.088=P |
| Butyrylcarnitine (C4) |
0.295 ± 0.28 |
0.313 ± 0.28 |
P= 0.352 |
| Isovalerylcarnitine (C5) |
0.133 ± 0.19 |
0.113 ± 0.04* |
<0.01 |
| Hexanoylcarnitine (C6) |
0.174 ± 0.02 |
0.140 ± 0.03* |
<0.01 |
| Octanoylcarnitine (C8) |
0.064 ± 0.03 |
0.0790 ± 0.03 |
P= 0.68 |
| Octenoylcarnitine (C8:1) |
0.141 ± 0.07 |
0.0982 ± 0.08* |
P= 0.019 |
| Decanoylcarnitine (C10) |
0.095 ± 0.05 |
0.173 ± 0.14 |
P=0.34 |
| Cecenoylcarnitine (C10:1) |
1.082 ± 0.75 |
0.856 ± 0.22* |
<0.01 |
| Lauroylcarnitine (C12) |
0.180 ± 0.25 |
0.058 ± 0.02 |
P= 0.94 |
| Myristoylcarnitine (C14) |
0.044 ± 0.02 |
0.0198 ± 0.03 |
P= 0.17 |
| Myristoleylcarnitine (C14:1) |
0.043 ± 0.02 |
0.023 ± 0.03* |
P<0.01 |
| Hydroxymyristoylcarnitine (C14OH) |
0.047 ± 0.02 |
0.0318 ± 0.01* |
P<0.01 |
| Palmitoylcarnitine (C16) |
0.172 ± 0.03 |
0.111 ± 0.03* |
P<0.01 |
| Palmitoleylcarnitine (C16:1) |
0.015 ± 0.01 |
0.0227 ± 0.01 |
P= 0.57 |
| Hydroxypalmitoleylcarnitine(C161OH) |
0.011 ± 0.01 |
0.013 ± 0.013 |
P=0.56 |
| Oleylcarnitine (C18:1) |
0.097 ± 0.03 |
0.119 ± 0.01 |
P=0.9 |
| Stearoylcarnitine (C18) |
0.148 ± 0.154 |
0.057 ± 0.02 * |
P<0.01 |
| Hydroxyoleylcarnitine (C18 OH) |
0.058 ± 0.0242 |
0.061 ± 0.01656 |
<0.4 |
